Sinanovic, E; Kumaranayake, L; (2010) The motivations for participation in public-private partnerships for the provision of tuberculosis treatment in South Africa. Global public health, 5 (5). pp. 479-492. ISSN 1744-1692 DOI: https://doi.org/10.1080/17441690902942498 Full text not available from this repository.

Cranny, G; Elliott, R; Weatherly, H; Chambers, D; Hawkins, N; Myers, L; Sculpher, M; Eastwood, A; (2008) A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery. Health technology assessment (Winchester, England), 12 (1). iii-iv, xi-xii, 1-147. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta12010

Sadique, MZ; Adams, EJ; Edmunds, WJ; (2008) Estimating the costs of school closure for mitigating an influenza pandemic. BMC public health, 8. p. 135. ISSN 1471-2458 DOI: https://doi.org/10.1186/1471-2458-8-135

Thomas, M; Care, P; Medicine, R; Doull, I; Price, D; Thomas, M; Hawkins, N; Stamuli, E; Tabberer, M; Gosden, T; +1 more... Rudge, H; (2007) Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma. Current medical research and opinion, 23. pp. 1147-59. ISSN 0300-7995 DOI: https://doi.org/10.1185/030079907X187982 Full text not available from this repository.

Brisson, M; Edmunds, WJ; (2006) Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs. Medical decision making, 26 (5). pp. 434-46. ISSN 0272-989X DOI: https://doi.org/10.1177/0272989X06290485 Full text not available from this repository.

Griffin, S; Claxton, K; Hawkins, N; Sculpher, M; (2006) Probabilistic analysis and computationally expensive models: Necessary and required? Value in health, 9. pp. 244-252. ISSN 1098-3015 DOI: https://doi.org/10.1111/j.1524-4733.2006.00107.x Full text not available from this repository.

Mackie, P; Sim, F; (2006) Cost and value: everything or nothing? Public health, 120 (4). pp. 281-2. ISSN 0033-3506 DOI: https://doi.org/10.1016/j.puhe.2006.02.001 Full text not available from this repository.

Yeung, RY; Smith, RD; Ho, LM; Johnston, JM; Leung, GM; (2006) Empirical implications of response acquiescence in discrete-choice contingent valuation. Health economics, 15 (10). pp. 1077-89. ISSN 1057-9230 DOI: https://doi.org/10.1002/hec.1107 Full text not available from this repository.

Smith, RD; Yago, M; Millar, M; Coast, J; (2005) Assessing the macroeconomic impact of a healthcare problem: The application of computable general equilibrium analysis to antimicrobial resistance. Journal of health economics, 24 (6). pp. 1055-75. ISSN 0167-6296 DOI: https://doi.org/10.1016/j.jhealeco.2005.02.003 Full text not available from this repository.

Jones, L; Griffin, S; Palmer, S; Main, C; Orton, V; Sculpher, M; Sudlow, C; Henderson, R; Hawkins, N; Riemsma, R; (2004) Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: A systematic review and economic evaluation. Health technology assessment (Winchester, England), 8 (38). iii-iv, 1-196. ISSN 1366-5278 https://researchonline.lshtm.ac.uk/id/eprint/2545583

Cooper, BS; Stone, SP; Kibbler, CC; Cookson, BD; Roberts, JA; Medley, GF; Duckworth, GJ; Lai, R; Ebrahim, S; (2003) Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health technology assessment (Winchester, England), 7 (39). pp. 1-194. ISSN 1366-5278 http://www.hta.ac.uk/fullmono/mon739.pdf

Gutierrez, JP; Bertozzi, SM; (2003) [The health gap in Mexico, measured through child mortality.]. Salud publica de Mexico, 45 (2). pp. 102-9. ISSN 0036-3634 DOI: https://doi.org/10.1590/S0036-36342003000200006

Yeung, RY; Smith, RD; McGhee, SM; (2003) Willingness to pay and size of health benefit: an integrated model to test for 'sensitivity to scale'. Health economics, 12 (9). pp. 791-6. ISSN 1057-9230 DOI: https://doi.org/10.1002/hec.786 Full text not available from this repository.

Beutels, P; Edmunds, WJ; Antonanzas, F; de Wit, GA; Evans, D; Feilden, R; Fendrick, AM; Ginsberg, GM; Glick, HA; Mast, E; +3 more... Pechevis, M; van Doorslaer, EK; van Hout, BA; (2002) Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis. PharmacoEconomics, 20 (1). pp. 1-7. ISSN 1170-7690 DOI: https://doi.org/10.2165/00019053-200220010-00001 Full text not available from this repository.

Boulle, A; Kenyon, C; Skordis, J; Wood, R; (2002) Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa. South African Medical Journal, 92 (10). pp. 811-7. ISSN 0256-9574 https://researchonline.lshtm.ac.uk/id/eprint/11150

Carabin, H; Edmunds, WJ; Kou, U; van Den Hof, S; Nguyen, VH; (2002) The average cost of measles cases and adverse events following vaccination in industrialised countries. BMC public health, 2. p. 22. ISSN 1471-2458 DOI: https://doi.org/10.1186/1471-2458-2-22

Clement, JP; White, KR; Valdmanis, V; (2002) Charity care: Do not-for-profits influence for-profits? Medical care research and review, 59 (1). pp. 59-78. ISSN 1077-5587 DOI: https://doi.org/10.1177/1077558702059001003 Full text not available from this repository.

Kanis, JA; Brazier, JE; Stevenson, M; Calvert, NW; Lloyd Jones, M; (2002) Treatment of established osteoporosis: a systematic review and cost-utility analysis. Health technology assessment (Winchester, England), 6 (29). pp. 1-146. ISSN 1366-5278 https://researchonline.lshtm.ac.uk/id/eprint/10372

Trotter, CL; Edmunds, WJ; (2002) Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales. BMJ, 324 (7341). p. 809. ISSN 0959-535X DOI: https://doi.org/10.1136/bmj.324.7341.809

Walker, D; Kumaranayake, L; (2002) Allowing for differential timing in cost analyses: discounting and annualization. Health policy and planning, 17 (1). pp. 112-8. ISSN 0268-1080 DOI: https://doi.org/10.1093/heapol/17.1.112 Full text not available from this repository.

Goodman, CA; Coleman, PG; Mills, AJ; (2001) Changing the first line drug for malaria treatment--cost-effectiveness analysis with highly uncertain inter-temporal trade-offs. Health economics, 10 (8). pp. 731-49. ISSN 1057-9230 DOI: https://doi.org/10.1002/hec.621 Full text not available from this repository.

Plowman, R; Graves, N; Esquive, J; Roberts, JA; (2001) An economic model to assess the cost and benefits of the routine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections in catheterized patients. The Journal of hospital infection, 48 (1). pp. 33-42. ISSN 0195-6701 DOI: https://doi.org/10.1053/jhin.2001.0938 Full text not available from this repository.

Suwandono, A; Gani, A; Purwani, S; Blas, E; Brugha, R; (2001) Cost recovery beds in public hospitals in Indonesia. Health policy and planning, 16 Sup. pp. 10-8. ISSN 0268-1080 https://researchonline.lshtm.ac.uk/id/eprint/17182 Full text not available from this repository.

Walker, D; Fox-Rushby, J; (2001) Allowing for uncertainty in economic evaluations: qualitative sensitivity analysis. Health policy and planning, 16 (4). pp. 435-43. ISSN 0268-1080 https://researchonline.lshtm.ac.uk/id/eprint/16802 Full text not available from this repository.